Comparison of 125I- and 111In-labeled monoclonal antibody BR96 for tumor targeting in combination with extracorporeal immunoadsorption

Clinical Cancer Research

Volumn 5, Issue 10 SUPPL., 1999, Pages

  Garkavij, Michael ^a   Tennvall, Jan ^a   Ohlsson, Tomas ^a   Lindgren, Lars ^a   Hindorf, Cecilia ^a   Sjögren, Hans Olov ^a   Strand, Sven Erik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BR96 I 125; MONOCLONAL ANTIBODY BR96 IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; INDIUM; RADIOACTIVE IODINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER TRANSPLANTATION; COLON CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DRUG TARGETING; IMMUNOADSORPTION; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RADIOISOTOPE DISTRIBUTION; RAT; ANIMAL; ARTICLE; BROWN NORWAY RAT; COMPARATIVE STUDY; EXTRACORPOREAL CIRCULATION; HUMAN; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODIES, MONOCLONAL; EXTRACORPOREAL CIRCULATION; HUMANS; INDIUM RADIOISOTOPES; IODINE RADIOISOTOPES; MALE; RATS; RATS, INBRED BN; TISSUE DISTRIBUTION;

EID: 0032589760     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Norrgren, K., Strand, S-E., Nilsson, R., Lindgren, L., and Sjogren, H. O. A general extracorporeal immunoadsorption method to increase tumor-to-normal tissue ratio in radioimmunoimaging and radioimmunotherapy. J. Nucl. Med., 34: 448-454, 1993.
2. Garkavij, M., Tennvall, J., Strand, S-E., Sjögren, H-O., Nilsson, R., and Lindgren, L. Improving radioimmunotargeting of tumors: variation in the amount of L6 MAB administered, combined with an immunoadsorption system (ECIA). Acta Oncol., 32: 853-859, 1993.
3. 125I-BR96-biotin in a syngeneic rat tumor model using whole blood extracorporeal immunoadsorption (WBIA). J. Nucl. Med., 38: 895-901, 1997.
4. 188Re-chiBR96. J. Nucl. Med., 38: 1934-1939, 1997.
5. DeNardo, S. J., Richman, C. M., Goldstein, D. S., Shen, S., Salako, Q., Kukis, D. L., Mears, C. F., Yuan, A., Welborn, J. L., and DeNardo, G. L. Yttrium-90/indium-111-dotapeptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer. Anticancer Res., 17: 1735-1744, 1997.
6. Sharkey, R. M., Behr, T. M., Mattes, M. J., Stein, R., Griffiths, G. L., Shih, L. B., Hansen, H. J., Blumenthal, R. D., Dunn, R. M., Juweid, M. E., and Goldenberg, D. M. Advantage of residualising radiolabels for an internalizing antibody against the B-cell lymphoma antigen CD22. Cancer Immunol. Immunother., 44: 179-188, 1997.
7. 90Y-hLL2 anti cd-22 Mab in patients with B-cell malignancies. 7th Conference on Radioimmunodetection and Radioimmunotherapy of Cancer, Princeton, 1998. Cancer Biother. Radiopharm., 13: 302, 1998.
8. Y-related cell surface antigens. Cancer Res., 50: 2183-2190, 1990.
9. 111In-labeled and biotinylated CDTA or DTPA monoclonal antibody conjugates. Tumor Targeting, I: 331-339, 1995.
10. 131I pair-labeled biotinylated chimeric BR96 in colon carcinoma isografted rats. Tumor Targeting, 2: 204-214, 1996.
11. Trail, P. A., Willner, D., and Lasch, S. J. Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science (Washington DC), 261: 212-215, 1993.
12. Y specific antibody with potent anti-tumor activity is internalized and degraded in lysosomes. Am. J. Pathol., 142: 607-622, 1993.
13. Chen, J. Q., Strand, S-E., and Sjögren, H-O. Optimization of radio-iodination and biotinylation of monoclonal antibody chiBR96: an indirect labeling usin n-succinimidyl-3-(3-n-butylstannyl)benzoate conjugate. Cancer Biother. Radiopharm., 11: 217-226, 1996.
14. 125I-labeled monoclonal antibody L6 in a nude rat model. Antibod. Immunoconjug. Radiopharm., 7: 29-42, 1994.
15. Strand, S-E., Norrgren, K., Garkavij, M., Lindgren, L., Nilsson, R., Sjögren, H. O., and Tennvall, J. Development of a general extracorporeal immunoadsorbtion method to increase tumor-to-nontumor ratio. Cancer (Phila.), 73 (Suppl.): 1033-1037, 1994.
16. Garkavij, M., Tennvall, J., Strand, S-E., Nilsson, R., Chen, J. Q., Lindgren, L., Isaksson, M., Eriksson, H., and Sjögren, H-O. Extracorporeal immunoadsorption (ECIA) from whole-blood based on avidinbiotin concept: evaluation of a new methodical approach. Acta Oncol., 35: 309-312, 1996.
17. Camero, L., Kinuya, S., Garmestani, K., Wu, C., Brechbiel, M. W., Pai, L. H., McCurry, T. J., Gansow, O. A., Pastan, I., Paik, C. H., and Carrasquillo, J. A. Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies. J. Nucl. Med., 35: 882-889, 1994.
18. Williams, L. E., Primus, F. J., Wong, J. Y. C., Wu, A. M., Odom-Maryon, T. L., Jonson, D. K., Hefta, L. J. F., Shively, J. E., and Raubitschek, A. A. Biodistribution of an indium-111- or yttrium-90-labelled chimeric anti-carcinoembrionic antigen monoclonal antibody (cT84.66) following its large scale production in a bioreactor. Tumor Targeting, 2: 116-124, 1996.
19. 111In-labeled anti-carcinoembrionic antigen monoclonal antibody in nude mice bearing human colon cancer xenografts. Cancer Res., 49: 1587-1594, 1989.
20. DeNardo, G. L., and DeNardo, S. J. Overview of obstacles and opportunities for radioimmunotherapy of cancer. In: D. M. Goldberg (ed.), Cancer Therapy with Radiolabeled Antibodies, pp. 141-154. Boca Raton, FL: CRC Press Inc., 1995.
21. Goldenberg, D. M. Monoclonal antibodies in cancer detection and therapy. Am. J. Med., 94: 297-312, 1993.
22. Blumenthal, R. D., Sharkey, R. M., Natale, A. M., Hess, J., and Goklenberg, D. M. Second antibody administration affects the immunogenicity of a primary xenogeneic antibody. Antibod. Immunoconjug. Radiopharm., 7: 43-55, 1994.
23. Wilbur, D. S., Hamlin, D. K., and Pathare, S. A. Synthesis and radiolabeling of water soluble, biotinidase resistant radioiodinated biotin derivatives. Sixth Conference on Radioimmunotherapy of Cancer, October 10-12, 1996, Princeton, NJ. Tumor Targeting, 2: 197-198, 1996.